• Title of article

    Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response

  • Author/Authors

    Ken Okumura، نويسنده , , Tomohiro Osanai، نويسنده , , Takuo Kosugi، نويسنده , , Hiroyuki Hanada، نويسنده , , Hiroshi Ishizaka، نويسنده , , Tomohisa Fukushi، نويسنده , , Takaatsu Kamada، نويسنده , , Takeshi Miura، نويسنده , , Toru Hatayama، نويسنده , , Takao Nakano، نويسنده , , Yasuhiro Fujino، نويسنده , , Yoshimi Homma، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2000
  • Pages
    6
  • From page
    1847
  • To page
    1852
  • Abstract
    OBJECTIVES We measured phospholipase C (PLC) activity in the cultured skin fibroblasts obtained from patients with and without coronary spasm and examined its correlation with coronary artery vasomotility. BACKGROUND Coronary artery vasomotility is enhanced in coronary spastic angina (CSA), but no information is available for the intracellular signaling. In spontaneously hypertensive rats, PLC activity in the skin fibroblasts has been shown to be enhanced. METHODS Skin fibroblasts obtained from 24 patients with CSA—14 with organic coronary artery disease (CAD) and 12 control subjects—were cultured by the explant method. Activity of PLC was determined by incubating the membrane fraction with 3H-phosphatidyl inositol bisphosphate and by quantifying 3H-inositol trisphosphate. In patients with CSA and control subjects, the relations between PLC activity and coronary artery basal tone and constrictor response to intracoronary acetylcholine (ACh) were examined. RESULTS Activity of PLC (pmol/protein [mg] per min) was 1.74 ± 0.19 in patients with CSA; 0.90 ± 0.12 in patients with CAD; and 0.65 ± 0.07 in control subjects (p < 0.001, patients with CSA vs. patients with CAD and control subjects; P = NS, patients with CAD vs. control subjects). According to the Lineweaver-Burk plot, Michaelis constant (μmol/liter) of PLC was 28 ± 4 in patients with CSA; 49 ± 14 in patients with CAD; and 56 ± 10 in control subjects (p < 0.05, patients with CSA vs. control subjects), whereas the maximal velocity was not different between the three groups. There were significant positive correlations between PLC activity and both basal tone (p = 0.0108) and response to ACh (p = 0.0053). Western blot analysis using membrane fraction demonstrated that 89% of PLC isoenzymes detected was of the δ1 isoform. CONCLUSIONS Because the PLC activity measured was genetically defined and was positively correlated with coronary artery vasomotility, enhanced PLC activity may be involved in the pathogenesis of coronary spasm.
  • Keywords
    4 , 5-trisphosphate , ISDN , Km , Inositol 1 , Michaelis constant , PIP2 , phosphatidyl inositol 4 , ACH , 5-bisphosphate , Acetylcholine , PKC , isosorbide dinitrate , CAD , protein kinase C , coronary artery disease , PLC , CSA , phospholipase C , coronary spastic angina , Vmax , IP3 , maximal velocity of reaction
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2000
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    596219